G&E Herbal Biotechnology Co., Ltd. (TPEX:4911)

G&E Herbal Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	59.57	152.59	139.68	114.75	12.28	14.46
Short-Term Investments	351.9	256.29	173.24	91.2	96.6	105.6
Cash & Short-Term Investments	411.47	408.87	312.92	205.95	108.88	120.06
Cash Growth	-	30.66%	51.94%	89.15%	-9.31%	-4.76%
Accounts Receivable	26.26	17.8	14.78	0.75	5.09	6.09
Other Receivables	0.22	0.16	0.15	0.02	0.03	0.04
Receivables	26.48	17.96	14.93	0.77	5.12	6.13
Inventory	24.05	21.71	22.9	24.64	19.83	16.98
Prepaid Expenses	1.97	2.38	1.41	1.32	2.07	2.97
Total Current Assets	463.97	450.92	352.17	232.69	135.9	146.14
Property, Plant & Equipment	368.59	372.31	375.12	375.15	382.85	389.74
Other Intangible Assets	132.88	133.33	133.89	134.68	135.51	136.11
Long-Term Deferred Tax Assets	0.34	0.26	19.65	37.95	37.59	39.26
Other Long-Term Assets	1.42	2.37	2.27	2.31	0.28	0.48
Total Assets	967.19	959.17	883.1	782.78	692.13	711.73
Accounts Payable	8.34	8.34	4.03	8.97	2.73	3.16
Accrued Expenses	11.07	17.72	17.34	8.11	1.64	1.56
Current Portion of Leases	0.89	0.88	0.69	-	-	-
Current Income Taxes Payable	11.97	3.1	-	-	-	-
Current Unearned Revenue	26.33	85.23	95.24	71.85	0.45	0.17
Other Current Liabilities	7.66	9.51	1.28	2.82	3.85	3.5
Total Current Liabilities	66.26	124.77	118.57	91.74	8.68	8.39
Long-Term Leases	0.2	0.87	1.29	-	-	-
Long-Term Deferred Tax Liabilities	-	-	-	0.2	-	-
Total Liabilities	66.46	125.64	119.86	91.94	8.68	8.39
Common Stock	637.2	590	556.6	556.6	556.6	556.6
Additional Paid-In Capital	134.24	134.24	134.24	273.33	273.33	273.33
Retained Earnings	129.31	109.3	72.4	-139.09	-146.47	-126.59
Shareholders' Equity	900.74	833.53	763.24	690.84	683.45	703.34
Total Liabilities & Equity	967.19	959.17	883.1	782.78	692.13	711.73
Total Debt	1.09	1.75	1.98	-	-	-
Net Cash (Debt)	410.38	407.13	310.94	205.95	108.88	120.06
Net Cash Growth	-	30.93%	50.98%	89.15%	-9.31%	-4.76%
Net Cash Per Share	6.43	6.38	4.88	3.23	1.71	1.88
Filing Date Shares Outstanding	63.72	63.72	63.72	63.72	63.72	63.72
Total Common Shares Outstanding	63.72	63.72	63.72	63.72	63.72	63.72
Working Capital	397.71	326.14	233.6	140.95	127.22	137.75
Book Value Per Share	14.14	13.08	11.98	10.84	10.73	11.04
Tangible Book Value	767.86	700.21	629.34	556.16	547.95	567.23
Tangible Book Value Per Share	12.05	10.99	9.88	8.73	8.60	8.90
Land	148.59	148.59	148.59	148.59	148.59	148.59
Buildings	233.86	233.58	233.58	233.08	233.39	233.31
Machinery	50.94	50.77	52.08	55.06	55.32	57.12
Construction In Progress	2.59	2.39	-	-	-	-
Leasehold Improvements	5.33	5.33	5.33	5.33	5.33	5.33

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.